You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

E7E6

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HPV Infection, HPV-Related Cervical Carcinoma Trial (FluBHPVE6E7, Placebo)

Not yet recruiting
  • HPV Infection
  • HPV-Related Cervical Carcinoma
  • FluBHPVE6E7
  • Placebo
  • (no location specified)
Apr 24, 2023

HPV-Related Carcinoma Trial (IBRX-042)

Not yet recruiting
  • HPV-Related Carcinoma
  • (no location specified)
Jul 26, 2023

Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor Trial (procedure, biological, drug)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Metastatic Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • (no location specified)
Dec 2, 2022

Old Age; Debility, Aging Trial in Canada (Virtual Reality)

Completed
  • Old Age; Debility
  • Aging
  • Virtual Reality
  • Fredericton, New Brunswick, Canada
  • +6 more
Jan 31, 2023

Head and Neck Squamous Cell Carcinoma, Melanoma, Cervical Cancer Trial in United States (RPTR-168)

Terminated
  • Head and Neck Squamous Cell Carcinoma
  • +2 more
  • RPTR-168
  • Scottsdale, Arizona
  • +3 more
Dec 2, 2022

COVID-19, Coronavirus Infections Trial in Halifax, Ottawa, Quebec (VBI-2901e)

Not yet recruiting
  • COVID-19
  • Coronavirus Infections
  • VBI-2901e
  • Halifax, Nova Scotia, Canada
  • +3 more
Dec 10, 2022

Male Erectile Disorder, Prostate Adenocarcinoma, Erectile Dysfunction, CTCAE Trial in Houston (Atorvastatin, Pentoxifylline,

Completed
  • Male Erectile Disorder
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 21, 2022

Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally

Recruiting
  • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • +5 more
  • Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
  • Pembrolizumab
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 4, 2023

Solid Tumor Trial in Wuhan (HPV-T, Interleukin-2)

Recruiting
  • Solid Tumor
  • Wuhan, Hubei, China
    Wuhan Union Hospital
May 31, 2023

Oropharyngeal Cancer, Human Papilloma Virus, Head Neck Cancer Trial (Fludarabine, Cyclophosphamide, NEXI-003 T cells)

Not yet recruiting
  • Oropharyngeal Cancer
  • +10 more
  • (no location specified)
Dec 14, 2022

Alzheimer, Subjective Cognitive Decline Trial in Toronto (Active Brainsway H7-Coil Deep TMS System, Sham Brainsway H7-Coil Deep

Recruiting
  • Alzheimer Disease
  • Subjective Cognitive Decline
  • Active Brainsway H7-Coil Deep TMS System
  • +2 more
  • Toronto, Ontario, Canada
    Rotman Research Institute at Baycrest
Oct 20, 2023

Adults With Severe Eosinophilic Asthma on Benralizumab.

Active, not recruiting
  • Severe Eosinophilic Asthma
  • Survey Administration
  • Calgary, Alberta, Canada
  • +19 more
Dec 1, 2022

Infertility, Fertility Issues, Infertility, Female Trial in Abu Dhabi, Dubai (diagnostic test, drug, procedure)

Not yet recruiting
  • Infertility
  • +2 more
  • Transvaginal ultrasound
  • +5 more
  • Abu Dhabi, United Arab Emirates
  • +1 more
Aug 6, 2023

Rectal Cancer Trial in Canada, United States (Folfox Protocol, Capox)

Active, not recruiting
  • Rectal Cancer
  • Orange, California
  • +10 more
Aug 22, 2022

Oropharyngeal Cancer Trial in Canada (Radiation, Cisplatin)

Active, not recruiting
  • Oropharyngeal Cancer
  • Prince George, British Columbia, Canada
  • +13 more
Dec 12, 2022

Aging Trial in Glendale

Withdrawn
  • Aging
  • (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol
  • Control
  • Glendale, Arizona
    Glencroft Senior Living: Retirement Community in Arizona
Jan 30, 2023

HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer Trial in Canada (Endocrine therapy may include one of the following

Active, not recruiting
  • HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
  • Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant
  • Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
  • Calgary, Alberta, Canada
  • +24 more
Sep 12, 2022

Disease Activity in Canadian Adult Moderate-to-Severe Atopic

Recruiting
  • Atopic Dermatitis
    • Calgary, Alberta, Canada
    • +17 more
    Jan 17, 2023

    Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

    Recruiting
    • Lymphoma, Non-Hodgkin
    • +2 more
    • Edmonton, Alberta, Canada
    • +9 more
    Jan 9, 2023

    HPV-Associated Cancers Trial in Canada, United States (Ad-E6E7, MG1-E6E7, Atezolizumab)

    Active, not recruiting
    • HPV-Associated Cancers
    • Ad-E6E7
    • +2 more
    • Miami, Florida
    • +7 more
    Sep 30, 2021

    E-cigarette Use Trial in Columbus (ECIG lab session 1, ECIG lab session 2, ECIG lab session 3)

    Recruiting
    • E-cigarette Use
    • ECIG lab session 1
    • +7 more
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Jul 13, 2022

    COVID-19, Coronavirus Infections Trial in Canada (VBI-2901a)

    Recruiting
    • COVID-19
    • Coronavirus Infections
    • VBI-2901a
    • Halifax, Nova Scotia, Canada
    • +6 more
    Nov 16, 2022

    Critical Illness Trial in Canada (Albumin Fluid Resuscitation Optimization Intervention, Usual Practice)

    Completed
    • Critical Illness
    • Albumin Fluid Resuscitation Optimization Intervention
    • Usual Practice
    • Calgary, Alberta, Canada
    • +14 more
    Oct 31, 2022

    Healthcare Resources in Chronic Lymphocytic Leukemia Initiating

    Completed
    • Chronic Lymphocytic Leukemia
      • Calgary, Alberta, Canada
      • +12 more
      Jul 7, 2022

      The Right Care, for Right Patient, at Right Time, by Right

      Not yet recruiting
      • Ambulatory Care
      • +3 more
      • On-site recruitment (information and consent) following a random sampling recruitment schedule
      • +2 more
      • Kingston, Ontario, Canada
      • +6 more
      May 26, 2023